Main Street Compounding Pharmacy Recalls Carnitine 250mg/ml Vials
Main Street Compounding Pharmacy is recalling Carnitine 250mg/ml vials due to reports of skin abscesses linked to a different compounded product.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves reports of skin abscesses, which constitute significant injury reports under the severity rubric.
Plain-English summary
Main Street Family Pharmacy, LLC is recalling Carnitine 250mg/ml vials. The recall involves 30 units distributed nationwide to specific states including AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV. All codes distributed prior to and including 05/23/2013 are affected.
The firm initiated this recall after receiving seven reports of adverse reactions in the form of skin abscesses. These reactions were potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials, a different product from the recalled Carnitine.
Consumers who possess the recalled Carnitine 250mg/ml vials should stop using them and contact Main Street Family Pharmacy, LLC at 888-658-6200 for further instructions.
The recalled product
- Product
- Carnitine 250mg/ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200
- Manufacturer
- Main Street Family Pharmacy, LLC
- Category
- Drug — Compounded Medication
- Affected units
- 30
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all codes distributed prior to and including 05/23/2013
Distribution
Part of a larger recall action
This product is one of 299 recalled by Main Street Family Pharmacy, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 299 products in this recall →Related recalls
Same manufacturer · Main Street Family Pharmacy, LLC
See all →- SevereMain Street Compounding Pharmacy Recalls Acetylcystein 10% Vials
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Minoxidil 10% Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls HCG 11000u w/B-12
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Brompheniramine Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Methylcobalamin Due to Adverse Reaction Reports
FDA (Drugs) · 2013-12-11
Same hazard · skin abscess
See all →- SevereMain Street Compounding Pharmacy Recalls Lipotropic 10ml with B-12 and L-Carnitine
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Testosterone Pellets Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
- SevereMain Street Compounding Pharmacy Recalls Dexamethasone LA Due to Adverse Reactions
FDA (Drugs) · 2013-12-11
Similar recalls
- SevereFDA Recalls Acetyl-L-Carnitine Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereCarnitine Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereAcetyl-L-Carnitine Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereUS Compounding Recalls Methylprednisolone Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- HighCompounded Injectable Medication Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-07-20
- HighCompounded injectable product recalled for lack of sterility assurance
FDA (Drugs) · 2022-07-20